Sign in

NCT03452202Recruiting

Using tDCS in Speech-based Stroke Rehabilitation

Source: ClinicalTrials.gov · Last updated 3 Jun 2026

Brief summary (registry, in English)

The purpose of this study is to determine whether the effect of treatment for acquired speech impairment can be enhanced by combining effective behavioral treatment with non-invasive brain stimulation. Transcranial direct current stimulation (tDCS), which delivers low-intensity current to the scalp, and is a safe and well-tolerated approach that poses a non-significant risk to participants. tDCS provides low intensity neural stimulation which has been shown to facilitate motor learning in other domains of stroke rehabilitation such as arm motor learning but the potential to enhance speech motor learning has not been explored. This will be examined with a series of single-case experimental designs.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
24 (estimated)
First submitted
16 Jan 2018
Start date
11 Jan 2019
Primary completion date
30 Apr 2027
Lead sponsor
NYU Langone Health
Diseases
Stroke
NCT number
NCT03452202

What you commit to

  • Study type: Interventional
  • Planned participants: 24
  • From 11 Jan 2019 to the primary completion date, 30 Apr 2027
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • History of speech impairment prior to CVA
  • Presence of electrically or magnetically activated implant (including pacemaker);

Other illness

  • Diagnosis of laryngeal voice disorder
  • history of medication-resistant epilepsy in the family;
  • past history of seizures or unexplained spells of loss of consciousness.

Other

  • Dysarthria
  • Presence of potential tDCS risk factors: damaged skin at site of stimulation;
  • metal in any part of their body;

Who the study is looking for

  • Right-handed
  • Monolingual (English)
  • Single left-hemisphere CVA
  • A minimum of six months post-stroke
  • Clinical diagnosis of apraxia of speech
  • Normal speech perception
  • Passing score on the hearing screening.

Age in the registry: 18 years to 99 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
New York University School of Medicine
Coordinator of this site? Confirm its status
New YorkUnited StatesRecruiting
Burke Rehabilitation Hospital
Coordinator of this site? Confirm its status
White PlainsUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.